- Home
- ONL vs NKTR Comparison
ONL vs NKTR Comparison
Compare ONL & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONL
- NKTR
- Stock Information
- Founded
- ONL 2021
- NKTR 1990
- Country
- ONL United States
- NKTR United States
- Employees
- ONL N/A
- NKTR N/A
- Industry
- ONL Real Estate Investment Trusts
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- ONL Real Estate
- NKTR Health Care
- Exchange
- ONL Nasdaq
- NKTR Nasdaq
- Market Cap
- ONL 119.7M
- NKTR 108.3M
- IPO Year
- ONL N/A
- NKTR 1994
- Fundamental
- Price
- ONL $2.32
- NKTR $24.25
- Analyst Decision
- ONL Hold
- NKTR Strong Buy
- Analyst Count
- ONL 1
- NKTR 6
- Target Price
- ONL N/A
- NKTR $81.67
- AVG Volume (30 Days)
- ONL 1.1M
- NKTR 4.8M
- Earning Date
- ONL 08-06-2025
- NKTR 08-07-2025
- Dividend Yield
- ONL 3.38%
- NKTR N/A
- EPS Growth
- ONL N/A
- NKTR N/A
- EPS
- ONL N/A
- NKTR N/A
- Revenue
- ONL $154,796,000.00
- NKTR $87,248,000.00
- Revenue This Year
- ONL N/A
- NKTR N/A
- Revenue Next Year
- ONL N/A
- NKTR N/A
- P/E Ratio
- ONL N/A
- NKTR N/A
- Revenue Growth
- ONL N/A
- NKTR N/A
- 52 Week Low
- ONL $1.46
- NKTR $6.48
- 52 Week High
- ONL $4.39
- NKTR $37.38
- Technical
- Relative Strength Index (RSI)
- ONL 56.92
- NKTR 63.40
- Support Level
- ONL $2.29
- NKTR $21.87
- Resistance Level
- ONL $2.41
- NKTR $26.59
- Average True Range (ATR)
- ONL 0.13
- NKTR 4.14
- MACD
- ONL 0.01
- NKTR 0.01
- Stochastic Oscillator
- ONL 63.05
- NKTR 54.77
About ONL Orion Office REIT Inc.
Orion Properties Inc is a internally-managed REIT engaged in the ownership, acquisition, and management of a diversified portfolio of mission-critical and headquarters office buildings located in high quality suburban markets across the U.S. and leased on a single-tenant net lease basis to creditworthy clients. The portfolio of the company includes traditional office buildings, governmental offices, medical offices, laboratories, and others. The Company operates in one business segment: direct ownership and operation of commercial real estate.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.